Literature DB >> 17643355

Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation.

Juan Xu1, Yi Sun, Junjie Huang, Chunmei Chen, Guoyuan Liu, Yan Jiang, Yaomin Zhao, Zhiyu Jiang.   

Abstract

In this paper, it was reported for the first time that the combination of the electroporation and the conjugation of the TiO(2) nanoparticles with the monoclonal antibody could improve the photokilling selectivity and efficiency of photoexcited TiO(2) on cancer cells in the photodynamic therapy(PDT) because the conjugation of the TiO(2) nanoparticles with monoclonal antibodies could increase the photokilling selectivity of TiO(2) nanoparticles to cancer cells and the electroporation could accelerate the delivery speed of the TiO(2) nanoparticles to cancer cells. It was observed that using this combination method, 100% human LoVo cancer cells were photokilled within 90 min, while only 39% of the normal cells were killed under the irradiation of the ultraviolet (UV) light (365 nm). Furthermore, the combination method may be used to photokill various kinds of caner cells only if the antibody conjugated on the TiO(2) nanoparticles is changed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643355     DOI: 10.1016/j.bioelechem.2007.06.001

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN: 1567-5394            Impact factor:   5.373


  20 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

2.  Self-assembled bionanoparticles based on the Sulfolobus tengchongensis spindle-shaped virus 1 (STSV1) coat protein as a prospective bioscaffold for nanotechnological applications.

Authors:  Lei Song; Haina Wang; Shiwen Wang; Hua Zhang; Haolong Cong; Li Huang; Po Tien
Journal:  Extremophiles       Date:  2014-06-06       Impact factor: 2.395

3.  Study on nanocomposite construction based on the multi-functional biotemplate self-assembled by the recombinant TMGMV coat protein for potential biomedical applications.

Authors:  Lei Song; Shiwen Wang; Haina Wang; Hua Zhang; Haolong Cong; Xingyu Jiang; Po Tien
Journal:  J Mater Sci Mater Med       Date:  2015-02-05       Impact factor: 3.896

4.  RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles - switchable integrin-targeted photodynamic treatment of melanoma cells.

Authors:  Avraham Dayan; Gideon Fleminger; Osnat Ashur-Fabian
Journal:  RSC Adv       Date:  2018-03-01       Impact factor: 4.036

5.  A high-performance nanobio photocatalyst for targeted brain cancer therapy.

Authors:  Elena A Rozhkova; Ilya Ulasov; Barry Lai; Nada M Dimitrijevic; Maciej S Lesniak; Tijana Rajh
Journal:  Nano Lett       Date:  2009-09       Impact factor: 11.189

Review 6.  Physical energy for drug delivery; poration, concentration and activation.

Authors:  Shanmugamurthy Lakshmanan; Gaurav K Gupta; Pinar Avci; Rakkiyappan Chandran; Magesh Sadasivam; Ana Elisa Serafim Jorge; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2013-06-07       Impact factor: 15.470

7.  Europium Doped TiO(2) Hollow Nanoshells: Two-Photon Imaging of Cell Binding.

Authors:  Sergio Sandoval; Jian Yang; Jesus G Alfaro; Alexander Liberman; Milan Makale; Casey E Chiang; Ivan K Schuller; Andrew C Kummel; William C Trogler
Journal:  Chem Mater       Date:  2012-10-01       Impact factor: 9.811

8.  Titanium dioxide in our everyday life; is it safe?

Authors:  Matej Skocaj; Metka Filipic; Jana Petkovic; Sasa Novak
Journal:  Radiol Oncol       Date:  2011-11-16       Impact factor: 2.991

9.  Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics.

Authors:  Chunqiu Zhao; Fawad Ur Rehman; Yanlong Yang; Xiaoqi Li; Dong Zhang; Hui Jiang; Matthias Selke; Xuemei Wang; Chongyang Liu
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

10.  Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.

Authors:  Angelica Sette; Jolanda Spadavecchia; Jessem Landoulsi; Sandra Casale; Bernard Haye; Olivia Crociani; Annarosa Arcangeli
Journal:  J Nanopart Res       Date:  2013-11-16       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.